164
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Analysis of interleukin 23 and 7G10 interactions for computational design of lead antibodies against immune-mediated inflammatory diseases

, , ORCID Icon, , , ORCID Icon & show all
Pages 327-334 | Received 25 Nov 2017, Accepted 12 Jul 2018, Published online: 01 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vinita Sharma, Priya Chouhan, Rajan Kumar Pandey, Rupal Ojha, Veeranarayanan Surya Aathmanathan, Muthukalingan Krishnan & Vijay Kumar Prajapati. (2021) Immunoglobulin interface redesigning to enhance lebrikizumab mediated immunomodulation of IL-13 hyper-response. Journal of Biomolecular Structure and Dynamics 39:11, pages 4051-4065.
Read now

Articles from other publishers (3)

Noor Saba Khan, Dibyabhaba Pradhan, Saumya Choudhary, Sandeep Swargam, Arun Kumar Jain & Nitesh Kumar Poddar. (2022) The interaction analysis between human serum albumin with chlorpyrifos and its derivatives through sub-atomic docking and molecular dynamics simulation techniques. 3 Biotech 12:10.
Crossref
Priya Chouhan, Satyendra Singh, Vinita Sharma & Vijay Kumar Prajapati. (2022) Anti-IL-10 Antibody Humanization by SDR Grafting with Enhanced Affinity to Neutralize the Adverse Response of Interleukin-10. International Journal of Peptide Research and Therapeutics 28:5.
Crossref
Ting Xin & Chengzhi Lu. (2020) Irisin activates Opa1-induced mitophagy to protect cardiomyocytes against apoptosis following myocardial infarction. Aging 12:5, pages 4474-4488.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.